Favourites   Have ideas?  Sign in / Register

Positive:   Biotechnology ↓7.62   Immunology 0.00   Disease: Addictions 0.00 «See more»   Pharmaceutical  ↑104.55   Disease: Metabolic disorders ↑104.55   Respiratory therapies / Pulmanory ↑104.55

Negative:


Disease: Central nervous system (CNS) segment

CYCN Cyclerion Therapeutics, Inc. - Common Stock 0 + Medicine, Disease: Central nervous system (CNS)

+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock 100% 100% 0 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine

+ My List
RLMD Relmada Therapeutics, Inc. - Common Stock -7.62% down -6.98% -0.64 + Disease: Central nervous system (CNS), Biotechnology, Medicine

+ My List
RVPH Reviva Pharmaceuticals Holdings, Inc. - Common Stock 104.55% 104.55% 0 + Medicine, Biopharma, Pharmaceutical , Disease: Metabolic disorders, Disease: Central nervous system (CNS), Respiratory therapies / Pulmanory

+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock 0 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)

+ My List
TRVN Trevena, Inc. - Common Stock -7.51% down -6.81% -0.7 + Biopharma, Medicine, Disease: Central nervous system (CNS)

+ My List
TSHA Taysha Gene Therapies, Inc. - Common Stock 3.42% up -0.43% 3.85 + Gene and cell, Disease: Central nervous system (CNS), Medicine

+ My List
TTNP Titan Pharmaceuticals, Inc. - Common Stock 0 + Biopharma, Disease: Central nervous system (CNS), Medicine

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.